Handelsbanken Fonder AB - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 133 filers reported holding ARCUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2022$222,000
+3.3%
8,5000.0%0.00%0.0%
Q2 2022$215,000
-19.8%
8,5000.0%0.00%0.0%
Q1 2022$268,000
-46.2%
8,500
-30.9%
0.00%
-50.0%
Q4 2021$498,000
+16.1%
12,3000.0%0.00%0.0%
Q3 2021$429,000
+26.9%
12,3000.0%0.00%0.0%
Q2 2021$338,00012,3000.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders